FDA.reportPublic FDA data

Trumenba vaccine 0.5 ML Prefilled Syringe

RxCUI
1593140
RxNorm name
Trumenba vaccine 0.5 ML Prefilled Syringe
Display name
Trumenba vaccine 0.5 ML Prefilled Syringe
Full name
Trumenba vaccine 0.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125549TrumenbaMeningococcal Group B Vaccine351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
bcaf5f75-caaf-41fd-875b-5800310070d1Trumenba vaccine 0.5 ML Prefilled SyringePSN23These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA ® (Meningococcal Group B Vaccine) Suspension for intramuscular injection Initial U.S. Approval: 201420260119
bcaf5f75-caaf-41fd-875b-5800310070d1Trumenba (meningococcal group B vaccine) 0.5 ML Prefilled SyringeSY23These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA ® (Meningococcal Group B Vaccine) Suspension for intramuscular injection Initial U.S. Approval: 201420260119
bcaf5f75-caaf-41fd-875b-5800310070d10.5 ML Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML Prefilled Syringe [Trumenba]SBD23These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA ® (Meningococcal Group B Vaccine) Suspension for intramuscular injection Initial U.S. Approval: 201420260119
bcaf5f75-caaf-41fd-875b-5800310070d1Trumenba (Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 60 MCG / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 60 MCG) per 0.5 ML Prefilled SyringeSY23These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA ® (Meningococcal Group B Vaccine) Suspension for intramuscular injection Initial U.S. Approval: 201420260119